10.1254/jphs.fp0060070 [DOI] [PubMed] [Google Scholar] Pevec D., Novinscak T., Brcic L., Sipos K., Jukic I., Staresinic M., et al
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that signals the pituitary gland to increase HGH production, while Ipamorelin is a selective growth hormone secretagogue (GHS) that stimulates growth hormone release without significantly impacting cortisol or prolactin levels
Additionally, the reduction in LC metabolite levels exhibited a significant correlation with cognitive enhancement subsequent to treatment [18]
The study shows that lipotoxicity, commonly linked to obesity and type 2 diabetes, increases the release to small extracellular vesicles (sEVs) causing impaired function of pancreatic insulinproducing cells and exacerbating type 2 diabetes
Hong S, Kim J, Na YS, Park J, Kim S, Singha K, Im G-I, Han D-K, Kim WJ, Lee H
ABP000198